Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Clinical benefits of 7 years of treatment with omalizumab in severe uncontrolled asthmatics.

Authors
  • Pace, Elisabetta
  • Ferraro, Maria
  • Bruno, Andreina
  • Chiappara, Giuseppina
  • Bousquet, Jean
  • Gjomarkaj, Mark
Type
Published Article
Journal
Journal of Asthma
Publisher
Informa UK (Taylor & Francis)
Publication Date
May 01, 2011
Volume
48
Issue
4
Pages
387–392
Identifiers
DOI: 10.3109/02770903.2011.561512
PMID: 21391878
Source
Medline
License
Unknown

Abstract

This study underlines the utility of a long-term treatment with omalizumab to improve asthma clinical outcomes in severe asthmatics.

Report this publication

Statistics

Seen <100 times